Cargando…

Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia

OBJECTIVE: The objective of this study was to comparatively analyse the gastric fluid (GF) microbiota between patients with functional dyspepsia (FD) and healthy controls (HC), and to assess the effect of probiotics on the microbiota. DESIGN: Twenty-four Japanese patients with FD who met the Rome II...

Descripción completa

Detalles Bibliográficos
Autores principales:	Igarashi, Muneki, Nakae, Hirohiko, Matsuoka, Takashi, Takahashi, Shunsuke, Hisada, Takayoshi, Tomita, Junko, Koga, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Functional and Motility Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508964/ https://www.ncbi.nlm.nih.gov/pubmed/28761692 http://dx.doi.org/10.1136/bmjgast-2017-000144

Ejemplares similares

Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt
por: Nakae, Hirohiko, et al.
Publicado: (2016)

Novel associations of bile acid diarrhoea with fatty liver disease and gallstones: a cohort retrospective analysis
por: Appleby, Richard N, et al.
Publicado: (2017)

‘What puts the ‘Hic’ into Hiccups?’
por: Seifi, Ali, et al.
Publicado: (2022)

Practical multidisciplinary framework for the assessment and management of patients with unexplained chronic aerodigestive symptoms
por: Quigley, Nathan, et al.
Publicado: (2023)

Persistent constipation and abdominal adverse events with newer treatments for constipation
por: Sonu, Irene, et al.
Publicado: (2016)

Incidence of ‘new-onset’ constipation and associated factors during lockdown due to the COVID-19 pandemic
por: Remes-Troche, Jose Maria, et al.
Publicado: (2021)

Functional bowel symptoms, fibromyalgia and fatigue: A food-induced triad?
por: Berstad, Arnold, et al.
Publicado: (2012)

Diagnostic pitfalls in functional neurological disorders
por: Pimentel, Lucio Huebra, et al.
Publicado: (2022)

Role of myosin Va in purinergic vesicular neurotransmission in the gut
por: Chaudhury, Arun, et al.
Publicado: (2012)

An organotypic slice model for ex vivo study of neural, immune, and microbial interactions of mouse intestine
por: Schwerdtfeger, Luke A., et al.
Publicado: (2015)

Hydroxy-α sanshool induces colonic motor activity in rat proximal colon: a possible involvement of KCNK9
por: Kubota, Kunitsugu, et al.
Publicado: (2015)

The role of K(+) conductances in regulating membrane excitability in human gastric corpus smooth muscle
por: Lee, Ji Yeon, et al.
Publicado: (2015)

Electrophysiological characterization of human rectal afferents
por: Ng, Kheng-Seong, et al.
Publicado: (2016)

Utility of wireless motility capsule and lactulose breath testing in the evaluation of patients with chronic functional bloating
por: Triadafilopoulos, George
Publicado: (2016)

Patients with symptoms of delayed gastric emptying have a high prevalence of oesophageal dysmotility, irrespective of scintigraphic evidence of gastroparesis
por: Triadafilopoulos, George, et al.
Publicado: (2017)

Clinical and manometric characteristics of patients with oesophagogastric outflow obstruction: towards a new classification
por: Triadafilopoulos, George, et al.
Publicado: (2018)

Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms
por: Su, Andrew, et al.
Publicado: (2017)

Evaluating the impact of an enhanced triage process on the performance and diagnostic yield of oesophageal physiology studies post COVID-19
por: Doyle, Rebecca, et al.
Publicado: (2021)

Rapid priority setting exercise on faecal incontinence for Cochrane Incontinence
por: Thomson, Katie H, et al.
Publicado: (2022)

miR‐10b‐5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes
por: Zogg, Hannah, et al.
Publicado: (2023)

A pilot genome‐wide association study meta‐analysis of gastroparesis
por: Tavares, Leticia Camargo, et al.
Publicado: (2023)

A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
por: Chey, William D, et al.
Publicado: (2011)

Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea
por: Pattni, Sanjeev S, et al.
Publicado: (2012)

Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
por: Emmanuel, Anton, et al.
Publicado: (2014)

Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome
por: Marquis, P, et al.
Publicado: (2014)

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
por: Rao, Satish, et al.
Publicado: (2012)

The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study
por: Riddle, Mark S, et al.
Publicado: (2016)

Association Between the Location of Diverticular Disease and the Irritable Bowel Syndrome: A Multicenter Study in Japan
por: Yamada, Eiji, et al.
Publicado: (2014)

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
por: Yiannakou, Yan, et al.
Publicado: (2015)

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
por: Jamal, M Mazen, et al.
Publicado: (2015)

The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden
por: Heidelbaugh, Joel J, et al.
Publicado: (2015)

The Effect of High-Fat Diet-Induced Pathophysiological Changes in the Gut on Obesity: What Should be the Ideal Treatment?
por: Y Lee, Chooi
Publicado: (2013)

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Schoenfeld, Philip, et al.
Publicado: (2018)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI
por: Lam, Ching, et al.
Publicado: (2017)

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
por: Miner Jr, Philip B, et al.
Publicado: (2017)

Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus
por: Rezaie, Ali, et al.
Publicado: (2017)

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
por: Chey, William D, et al.
Publicado: (2017)

Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome
por: Sayuk, Gregory S, et al.
Publicado: (2017)

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use
por: Lacy, Brian E, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fivincenkte5et55ugii043c3n